Agmatine · Evidence-based safety and harm-reduction overview.
| Also known as | Agmatine |
| Category | Nootropic |
| endogenous | Produced naturally from L-arginine in body |
| neuromodulator | Recognized signaling molecule in nervous system |
| human_evidence | Sparse; mostly preclinical research |
| US legal status | Dietary supplement, unregulated; US legal to buy and use. Not approved by FDA as a new dietary ingredient formally but widely available |
Decarboxylation product of L-arginine; supports nitric oxide production, neuroprotection, and stress response. Also a signaling molecule and neuromodulator in nervous system.
Agmatine inhibits nitric oxide synthase at low doses (neuroprotection) and enhances it at higher doses (vasodilation). Acts as neuromodulator at NMDA, AMPA, and other ion channels. Modulates polyamine pathways and imidazoline receptor signaling.
Identified as endogenous neuromodulator in 1990s; synthesized from arginine via arginine decarboxylase. Interest in supplementation for mood and neuroprotection emerged in 2000s; human application remains experimental.
Animal evidence for neuroprotection and mood support; limited human data; some studies in pain and mood conditions. Mechanistic studies in vitro and in vivo animals robust; clinical translation minimal.
Supplement labels suggest 500-1500 mg daily in divided doses. No published human dose-response studies; dosing derived from animal models and user reports.
This is general research/context information, not medical advice or a recommended protocol.
Sometimes combined with L-arginine or citrulline for nitric oxide enhancement, though additive effects unproven. May stack with mood-support compounds.
L-arginine or beetroot juice. Better-established nitric oxide and blood flow support with stronger safety and efficacy evidence
See our recommended pickIf you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsAnimal evidence supports nitric oxide promotion; direct human cardiovascular benefit is unproven
Long-term safety unpublished in humans; short-term use appears safe
Yes, chemically derived from L-arginine via enzymatic decarboxylation; different mechanism
Animal evidence suggests potential; human mood efficacy unproven
Blood pressure medication interactions theoretical; medical supervision recommended if on antihypertensives
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.